• Masoondarou Biopharma was established in 2007 as a knowledge-based company in Iran, by development of technology for production of biopharmaceutical products, human vaccines and new high-tech medicines to combat diseases and promote health in the country. • This company won the first rank in the Technopinners section in the 8th Sheikh Baha’i National Technopreneurship Festival in 2012 • This knowledge-based company tries to produce novel-technology based biotechnological drugs by attracting specialized and expert employees. MasoonDarou is the first and only pharmaceutical company in Iran that produces monovalent and polyvalent antitoxins of Clostridium botulinum, Haemophilus influenzae type B conjugate vaccine under the brand name MAS-Hib VAC®️ and Clostridium botulinum toxin type A under the brand name MASPORT¬®️. The products of MasoonDarou Company are of excellent quality and are produced according to American and European standards. The amount of production capacity in this company is several times more than the amount needed by the consumers in the country.In addition to fully meeting the needs of the country, the products of MasoonDarou company have been imported to all parts of the world’s markets in Asia, Europe, America, Africa and Oceania, and have been highly welcomed due to their high quality.

• Training qualified persons and employment expert human resources
• Design and construction of production and laboratory facilities according to current GMP, GLP and Biosafety standards
• Leading applied researches to promote community health
• Promoting national and international network communication of researchers The vision of Masoondarou is trying to produce all the new generation immunopharmacological products required by the country according to the standards of the World Health Organization. The core values of this company
• Perform all tasks in highest possible level
• Creating a suitable motivational environment for all employees to produce high quality products
• Improving people’s health
• Preservation of human dignity and values
• Strengthen the professional skills of employees
• Creating a culture of innovation
• Optimal use of national resources